Medicare Enrolled
George Zlupko
Pulmonary Disease · Altoona, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Zlupko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Zlupko?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Zlupko
George Zlupko is a pulmonary disease specialist in Altoona, PA, with 20 years of NPI registration. Based on federal Medicare data, Zlupko performed 1,077 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Zlupko received a total of $38,672 from 55 pharmaceutical and/or device companies across 1128 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Zlupko is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 28% volume in PA
$38,672 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,077
Medicare services
Top 28% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $90 | $170 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
218 | $18 | $82 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
74 | $29 | $60 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
64 | $14 | $85 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
60 | $21 | $103 |
| Exhaled air and carbon dioxide test A test that measures exhaled air and carbon dioxide levels to evaluate lung function. |
53 | $33 | $75 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
53 | $36 | $70 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
38 | $35 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $112 | $185 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $48 | $100 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
31 | $23 | $75 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
29 | $9 | $93 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
29 | $2 | $15 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
24 | $23 | $25 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
21 | $72 | $100 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
21 | $32 | $180 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
11 | $13 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$38,672
Total received (2018-2024)
Avg $5,525/year across 7 years
Top 9% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
1,128
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,630
2023
$2,783
2022
$2,612
2021
$2,937
2020
$2,256
2019
$8,411
2018
$16,044
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$707
GlaxoSmithKline, LLC.
$649
Boehringer Ingelheim Pharmaceuticals, Inc.
$297
Regeneron Healthcare Solutions, Inc.
$272
Actelion Pharmaceuticals US, Inc.
$216
United Therapeutics Corporation
$169
Avadel CNS Pharmaceuticals, LLC
$168
JAZZ PHARMACEUTICALS INC.
$160
GENZYME CORPORATION
$152
Inspire Medical Systems, Inc.
$121
Mallinckrodt Hospital Products Inc.
$118
Amgen Inc.
$88
Electromed, Inc.
$77
Mylan Specialty L.P.
$62
Genentech USA, Inc.
$61
Philips North America LLC
$58
Axsome Therapeutics, Inc.
$54
Merck Sharp & Dohme LLC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$36
Pulmonx Corporation
$31
Resmed Corp
$31
ABBVIE INC.
$19
Insmed, Inc.
$17
Grifols USA, LLC
$16
Top 3 companies account for 45.5% of 2024 payments
All-time payments by company (2018-2024) ›
Actelion Pharmaceuticals US, Inc.
$11,105
Mylan Specialty L.P.
$6,152
AstraZeneca Pharmaceuticals LP
$4,112
Gilead Sciences, Inc.
$3,551
GlaxoSmithKline, LLC.
$3,242
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,582
Regeneron Healthcare Solutions, Inc.
$819
GENZYME CORPORATION
$721
Grifols USA, LLC
$647
United Therapeutics Corporation
$618
JAZZ PHARMACEUTICALS INC.
$592
PFIZER INC.
$586
Electromed, Inc.
$532
Insmed, Inc.
$390
Genentech USA, Inc.
$387
Harmony Biosciences LLC
$280
Takeda Pharmaceuticals U.S.A., Inc.
$260
Mallinckrodt Hospital Products Inc.
$234
Novartis Pharmaceuticals Corporation
$214
Jazz Pharmaceuticals Inc.
$209
Philips Electronics North America Corporation
$196
Veran Medical Technologies, Inc.
$193
Avadel CNS Pharmaceuticals, LLC
$168
Merck Sharp & Dohme LLC
$143
Advanced Respiratory, Inc
$141
Inspire Medical Systems, Inc.
$139
SANOFI-AVENTIS U.S. LLC
$135
Resmed Corp
$129
Amgen Inc.
$108
AbbVie Inc.
$102
ZOLL Respicardia, Inc.
$81
Teva Pharmaceuticals USA, Inc.
$74
Shire North American Group Inc
$68
Sunovion Pharmaceuticals Inc.
$68
Baxter Healthcare
$62
Philips North America LLC
$58
Circassia Pharmaceuticals Inc
$57
Axsome Therapeutics, Inc.
$54
Pulmonx Corporation
$46
Merck Sharp & Dohme Corporation
$44
Allergan, Inc.
$40
ADVANCED RESPIRATORY, INC
$39
Vapotherm Inc
$36
Smith+Nephew, Inc.
$32
Optinose US, Inc.
$30
Allergan Inc.
$28
Alexion Pharmaceuticals, Inc.
$28
RedDress USA, Inc.
$22
Paratek Pharmaceuticals, Inc.
$21
Eisai Inc.
$19
ABBVIE INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$17
Bayer HealthCare Pharmaceuticals Inc.
$13
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ALLEVYN GENTLE BORDER · ANORO · ANORO ELLIPTA · APNEALINK · AREXVY · ASMANEX · AVYCAZ · Adempas · AirDuo Digihaler · AirSense · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLUARIX · FLULAVAL · GLASSIA · Grafix PL PRIME · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · INSPIRE · KEYTRUDA · LO LOESTRIN FE · LONHALA MAGNAIR · LUMRYZ · Letairis · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 13 · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · SHINGRIX · SMARTVEST · SOLIRIS · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Ultomiris · Utibron · VAPOTHERM · WAKIX · WINREVAIR · Wakix · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
6
County median income
$60,594
Nearest hospital to ZIP centroid (approximate)
UPMC ALTOONA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Zlupko is a clinical cardiology specialist, with above-average Medicare volume (top 28% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Zlupko experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Zlupko performed 282 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Zlupko receive payments from pharmaceutical companies?
Yes. Zlupko received a total of $38,672 from 55 companies across 1,128 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Zlupko's costs compare to other pulmonary diseases in Altoona?
Zlupko's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Zlupko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Altoona
Browse pulmonary diseases in Altoona ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology